PIMCO California Municipal Income Fund II (PCK) At $8.22 Forms Bottom; Scopia Capital Management LP Has Decreased By $16.90 Million Its Horizon Pharma Plc (HZNP) Position

Horizon Pharma Public Limited Company (NASDAQ:HZNP) Logo

Scopia Capital Management Lp decreased Horizon Pharma Plc (HZNP) stake by 7.37% reported in 2018Q1 SEC filing. Scopia Capital Management Lp sold 1.21 million shares as Horizon Pharma Plc (HZNP)’s stock rose 10.83%. The Scopia Capital Management Lp holds 15.16 million shares with $215.32M value, down from 16.37 million last quarter. Horizon Pharma Plc now has $2.88B valuation. The stock increased 0.06% or $0.01 during the last trading session, reaching $17.44. About 1.49 million shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has risen 62.19% since June 14, 2017 and is uptrending. It has outperformed by 49.62% the S&P500. Some Historical HZNP News: ; 09/05/2018 – Horizon Pharma 1Q EBITDA $33.6M; 09/05/2018 – HORIZON PHARMA PLC HZNP.O SEES FY 2018 SALES $1.17 BLN TO $1.2 BLN; 21/05/2018 – Horizon Pharma Presenting at UBS Conference Tomorrow; 03/05/2018 – Horizon Pharma plc Announces Sangita lyer as a 2018 Healthcare Businesswomen’s Association Rising Star; 08/05/2018 – Horizon Pharma Announces the U.S. Patent and Trademark Office Issued Additional Notices of Allowance With Claims Covering Ravicti Oral Liquid; 03/05/2018 – AGC BIOLOGICS SAYS ENTERS INTO COMMERCIAL MANUFACTURING AGREEMENT WITH HORIZON PHARMA PLC FOR COMMERCIAL SUPPLY OF TEPROTUMUMAB; 09/05/2018 – HORIZON PHARMA PLC – SEES 2018 ADJ EBITDA GUIDANCE RANGE TO $390 MLN TO $415 MLN; 09/05/2018 – HORIZON PHARMA 1Q ADJ EPS 3C, EST. 6C; 12/04/2018 – Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to Work® and FORTUNE; 30/05/2018 – Horizon Pharma Presenting at Goldman Sachs Conference Jun 12

PIMCO California Municipal Income Fund II (PCK) formed multiple bottom with $7.73 target or 6.00% below today’s $8.22 share price. PIMCO California Municipal Income Fund II (PCK) has $262.78M valuation. The stock increased 0.12% or $0.01 during the last trading session, reaching $8.22. About 44,770 shares traded. PIMCO California Municipal Income Fund II (NYSE:PCK) has declined 19.15% since June 14, 2017 and is downtrending. It has underperformed by 31.72% the S&P500.

Investors sentiment increased to 1.38 in Q1 2018. Its up 0.09, from 1.29 in 2017Q4. It is positive, as 1 investors sold PIMCO California Municipal Income Fund II shares while 7 reduced holdings. 7 funds opened positions while 4 raised stakes. 1.98 million shares or 128.26% more from 868,231 shares in 2017Q4 were reported. Laurion Cap Ltd Partnership stated it has 877,742 shares. Stratos Wealth Prtnrs has invested 0% in PIMCO California Municipal Income Fund II (NYSE:PCK). Citigroup Inc accumulated 97,037 shares. Suntrust Banks invested in 150,018 shares. Morgan Stanley holds 106,532 shares or 0% of its portfolio. Cambridge Inv Rech Advisors holds 0.01% or 61,878 shares. Oppenheimer, New York-based fund reported 14,964 shares. 12,290 are held by Lpl Fin Limited Liability Co. Susquehanna Grp Limited Liability Partnership reported 52,279 shares. 19,387 are owned by Pure Advsr. Citadel Advisors Limited Liability Corp holds 11,157 shares or 0% of its portfolio. Moreover, Rmb Capital Ltd Company has 0% invested in PIMCO California Municipal Income Fund II (NYSE:PCK) for 17,461 shares. Wolverine Asset Management Limited Liability accumulated 0.01% or 111,575 shares. Royal Bancorporation Of Canada holds 0% in PIMCO California Municipal Income Fund II (NYSE:PCK) or 18,003 shares. Guggenheim Cap Ltd Liability invested in 0% or 195,288 shares.

Analysts await Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report earnings on August, 6. They expect $0.33 EPS, down 19.51% or $0.08 from last year’s $0.41 per share. HZNP’s profit will be $54.46M for 13.21 P/E if the $0.33 EPS becomes a reality. After $0.03 actual EPS reported by Horizon Pharma Public Limited Company for the previous quarter, Wall Street now forecasts 1,000.00% EPS growth.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma has $40 highest and $900 lowest target. $21.15’s average target is 21.27% above currents $17.44 stock price. Horizon Pharma had 63 analyst reports since September 9, 2015 according to SRatingsIntel. Mizuho maintained the shares of HZNP in report on Monday, August 7 with “Hold” rating. The firm has “Buy” rating by Jefferies given on Friday, October 13. On Wednesday, February 28 the stock rating was maintained by Cowen & Co with “Buy”. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Buy” rating given on Tuesday, May 3 by Mizuho. Jefferies initiated Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Tuesday, January 19. Jefferies has “Buy” rating and $31 target. Stifel Nicolaus maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Tuesday, June 27. Stifel Nicolaus has “Buy” rating and $2000 target. As per Wednesday, April 11, the company rating was maintained by Mizuho. Cowen & Co downgraded the shares of HZNP in report on Friday, September 16 to “Market Perform” rating. On Friday, October 9 the stock rating was initiated by Mizuho with “Buy”. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Buy” rating given on Sunday, July 30 by Cantor Fitzgerald.

Investors sentiment increased to 1.38 in 2018 Q1. Its up 0.34, from 1.04 in 2017Q4. It improved, as 12 investors sold HZNP shares while 53 reduced holdings. 36 funds opened positions while 54 raised stakes. 127.87 million shares or 0.61% less from 128.65 million shares in 2017Q4 were reported. Cubist Systematic Strategies Ltd reported 74,734 shares. Point72 Asia (Hong Kong) Limited owns 0.01% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 1,377 shares. Swiss National Bank & Trust stated it has 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). First LP owns 0% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 136,717 shares. D E Shaw And has invested 0.01% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Moreover, Paloma Prns Management Commerce has 0.01% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 28,447 shares. 1,150 were accumulated by Atlantic Trust Group Inc Llc. Leavell Investment Management has 0.02% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 10,000 shares. Invesco Ltd holds 167,336 shares or 0% of its portfolio. Deltec Asset Limited Liability Company has 21,700 shares. 1492 Limited Liability holds 0.51% or 46,875 shares. Massachusetts Financial Ser Co Ma holds 0% or 95,128 shares in its portfolio. Proshare Advsr Ltd Limited Liability Company has invested 0.01% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). United Service Automobile Association owns 24,357 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 11,122 shares.

More important recent Horizon Pharma Public Limited Company (NASDAQ:HZNP) news were published by: Nasdaq.com which released: “Report: Exploring Fundamental Drivers Behind Horizon Pharma Public, Lululemon Athletica, Nordic American Tankers …” on June 07, 2018, also Nasdaq.com published article titled: “Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare …”, Nasdaq.com published: “Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference” on May 30, 2018. More interesting news about Horizon Pharma Public Limited Company (NASDAQ:HZNP) was released by: Nasdaq.com and their article: “Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with …” with publication date: May 22, 2018.

Since May 25, 2018, it had 0 buys, and 3 sales for $1.91 million activity. 15,433 Horizon Pharma Public Limited Company (NASDAQ:HZNP) shares with value of $271,249 were sold by Beeler Brian K. On Friday, June 1 Walbert Timothy P sold $1.35M worth of Horizon Pharma Public Limited Company (NASDAQ:HZNP) or 83,353 shares.

Scopia Capital Management Lp increased Plains Gp Hldgs LP stake by 21,739 shares to 9.30M valued at $202.37M in 2018Q1. It also upped Forest City Rlty Tr Inc stake by 121,729 shares and now owns 22.09 million shares. Ptc Therapeutics Inc (NASDAQ:PTCT) was raised too.

Horizon Pharma Public Limited Company (NASDAQ:HZNP) Ratings Chart